image_2_Interleukin-1α Mediates Ozone-Induced Myeloid Differentiation Factor-88-Dependent Epithelial Tissue Injury and Inflammation.tiff
Air pollution associated with ozone exposure represents a major inducer of respiratory disease in man. In mice, a single ozone exposure causes lung injury with disruption of the respiratory barrier and inflammation. We investigated the role of interleukin-1 (IL-1)-associated cytokines upon a single ozone exposure (1 ppm for 1 h) using IL-1α-, IL-1β-, and IL-18-deficient mice or an anti-IL-1α neutralizing antibody underlying the rapid epithelial cell death. Here, we demonstrate the release of the alarmin IL-1α after ozone exposure and that the acute respiratory barrier injury and inflammation and airway hyperreactivity are IL-1α-dependent. IL-1α signaling via IL-1R1 depends on the adaptor protein myeloid differentiation factor-88 (MyD88). Importantly, epithelial cell signaling is critical, since deletion of MyD88 in lung type I alveolar epithelial cells reduced ozone-induced inflammation. In addition, intratracheal injection of recombinant rmIL-1α in MyD88acid mice led to reduction of inflammation in comparison with wild type mice treated with rmIL-1α. Therefore, a major part of inflammation is mediated by IL-1α signaling in epithelial cells. In conclusion, the alarmin IL-1α released upon ozone-induced tissue damage and inflammation is mediated by MyD88 signaling in epithelial cells. Therefore, IL-1α may represent a therapeutic target to attenuate ozone-induced lung inflammation and hyperreactivity.
History
References
- https://doi.org//10.1111/j.1365-2222.2011.03776.x
- https://doi.org//10.1016/S0098-2997(00)00003-0
- https://doi.org//10.1093/toxsci/68.2.488
- https://doi.org//10.1016/j.immuni.2014.01.011
- https://doi.org//10.1165/rcmb.2015-0165OC
- https://doi.org//10.1002/eji.201646366
- https://doi.org//10.1371/journal.pone.0027137
- https://doi.org//10.1016/S0167-4889(02)00320-8
- https://doi.org//10.1152/japplphysiol.00172.2007
- https://doi.org//10.1289/ehp.1003326
- https://doi.org//10.1016/j.jaci.2010.03.001
- https://doi.org//10.1016/j.cyto.2015.06.017
- https://doi.org//10.1146/annurev-physiol-030212-183756
- https://doi.org//10.1038/ni.3370
- https://doi.org//10.1038/ni.3045
- https://doi.org//10.1002/eji.201041033
- https://doi.org//10.1002/eji.200323801
- https://doi.org//10.1016/j.pupt.2017.03.008
- https://doi.org//10.1165/rcmb.2007-0250OC
- https://doi.org//10.1080/15287394.2014.971924
- https://doi.org//10.1165/rcmb.2003-0373OC
- https://doi.org//10.1165/rcmb.2006-0315OC
- https://doi.org//10.1371/journal.pone.0169209
- https://doi.org//10.1165/rcmb.2008-0045OC
- https://doi.org//10.1093/jmcb/mjv012
- https://doi.org//10.1016/j.immuni.2015.02.011
- https://doi.org//10.1289/EHP272
- https://doi.org//10.1016/j.jaci.2017.11.044
- https://doi.org//10.1093/ajcn/83.2.447S
- https://doi.org//10.4049/jimmunol.167.9.5338
- https://doi.org//10.1172/JCI7317
- https://doi.org//10.1681/ASN.2008020170
- https://doi.org//10.1016/S1074-7613(00)80086-2
- https://doi.org//10.1165/rcmb.2009-0226OC
- https://doi.org//10.1084/jem.187.9.1463
- https://doi.org//10.1371/journal.pone.0058452
- https://doi.org//10.1084/jem.20071507
- https://doi.org//10.1289/ehp.1205188
- https://doi.org//10.1016/j.it.2015.06.003
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity